Ponatinib (AP24534)

Catalog No.S1490

Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.

Price Stock Quantity  
USD 100 In stock
USD 110 In stock
USD 370 In stock
USD 970 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Ponatinib (AP24534) Chemical Structure

Ponatinib (AP24534) Chemical Structure
Molecular Weight: 532.56

Validation & Quality Control

2 customer reviews :

Quality Control & MSDS

Related Compound Libraries

Bcr-Abl Inhibitors with Unique Features

  • Selective Bcr-Abl Inhibitor

    Nilotinib (AMN-107) Bcr-Abl-selective, IC50<30 nM.

  • Most Potent Bcr-Abl Inhibitor

    GZD824 Bcr-Abl(WT), IC50=0.34 nM; Bcr-Abl(T315I), IC50=0.68 nM.

  • FDA-approved Bcr-Abl Inhibitor

    Dasatinib Approved by FDA for CML and Ph+ ALL.

  • Newest Bcr-Abl Inhibitor

    GZD824 Orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Product Information

  • Compare Bcr-Abl Inhibitors
    Compare Bcr-Abl Products
  • Research Area
  • Ponatinib (AP24534) Mechanism

Product Description

Biological Activity

Description Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.
Targets Abl [1]
(Cell-free assay)
PDGFRα [1]
(Cell-free assay)
VEGFR2 [1]
(Cell-free assay)
FGFR1 [1]
(Cell-free assay)

 View  More

IC50 0.37 nM 1.1 nM 1.5 nM 2.2 nM
In vitro AP24534 potently inhibits native Abl, AblT315I, and other clinically important Abl kinase domain mutants with IC50 of 0.30 nM–2 nM. AP24534 doesn't inhibit Aurora kinase family members, nor does it inhibit insulin receptor or CDK2/cyclin E. AP24534 inhibits proliferation of Ba/F3 cells expressing Bcr-Abl with IC50 of 0.5 nM, as well as Ba/F3 cells expressing a range of Bcr-Abl mutants with IC50 of 0.5 nM–36 nM. The inhibition of proliferation by AP24534 is correlated with induction of apoptosis. [1-2] In leukemic cell lines containing activated forms of FLT3, KIT, FGFR1, and PDGFRα receptors, AP24534 potently inhibits receptor phosphorylation and cellular proliferation with IC50 of 0.3 nM to 20 nM. In MV4-11 (FLT3-ITD(+/+)) but not RS4;11 (FLT3-ITD(–/–)) AML cells, AP24534 inhibits FLT3 signaling and induced apoptosis at less than 10 nM. AP24534 inhibits viability of primary leukemic blasts from a FLT3-ITD positive AML patient with IC50 of 4 nM but not those from patients with AML expressing native FLT3. [3] In Ba/F3 cells engineered to express activated FGFR1-4, AP24534 potently inhibits FGFR-mediated signaling and viability with IC50 lower than 40 nM. In cell lines representing multiple tumor types (endometrial, bladder, gastric, breast, lung, and colon), and containing FGFRs dysregulated by a variety of mechanisms, AP24534 inhibits FGFR-mediated signaling with IC50 less than 40 nM and inhibits cell growth with IC50 of 7 nM–181 nM. [4]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
EoL-1-cellMl3PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWXnb2xkUUN3ME2wMlAxODByMECzOVkh|ryPMXHTRW5ITVJ?
MV-4-11MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4nNdGlEPTB;MD6wNFAxQTV4IN88US=>NG\rPHdUSU6JRWK=
MEG-01MnfsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH\lWYhKSzVyPUCuNFAxOTJ6IN88US=>NIn4UIxUSU6JRWK=
LAMA-84MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVvJR|UxRTBwMECwNVY2KM7:TR?=NF;iUIxUSU6JRWK=
CGTH-W-1M4jueWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mm\4TWM2OD1yLkCwNVY6KM7:TR?=NVnFNlhGW0GQR1XS
KASUMI-1NW[0PWFXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTBwMECyNVch|ryPM{flcXNCVkeHUh?=
BE-13NFzXbYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVPo[IJ[UUN3ME2wMlAxOjV7IN88US=>NX\2OXZ6W0GQR1XS
CTV-1MkXRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnTLTWM2OD1yLkCwOVIyKM7:TR?=MV;TRW5ITVJ?
NKM-1NFXDPFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3;2ZmlEPTB;MD6wNFY2PSEQvF2=M1PhNXNCVkeHUh?=
MONO-MAC-6MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWTqNYhSUUN3ME2wMlAxQDN5IN88US=>NHHydZNUSU6JRWK=
A204MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWjQOWc3UUN3ME2wMlAyOjF6IN88US=>Mon6V2FPT0WU
GDM-1M4TVOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYLJR|UxRTBwMEG4N|Mh|ryPMmSxV2FPT0WU
AN3-CAMVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWP0dpZbUUN3ME2wMlAyQDd|IN88US=>M1jIZnNCVkeHUh?=
BL-70MlHoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGT6PXNKSzVyPUCuNFIyQTlizszNMkLkV2FPT0WU
DaudiMUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHhTWM2OD1yLkCyOVM4KM7:TR?=M2S1TnNCVkeHUh?=
KU812NYDIWIVZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVXu[oVtUUN3ME2wMlAzQDR6IN88US=>NWjVPHZ1W0GQR1XS
KG-1MlLyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDCb5FWUUN3ME2wMlA{Ojl2IN88US=>MVPTRW5ITVJ?
DOHH-2M{P6N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmD3TWM2OD1yLkC0PFA{KM7:TR?=MoTmV2FPT0WU
HuO9MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnHBTWM2OD1yLkC1OFQ5KM7:TR?=NIrtTlFUSU6JRWK=
EB2NF\WflNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYTJR|UxRTBwMEW1O|Yh|ryPMnLpV2FPT0WU
G-402NF:yRmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULyOotUUUN3ME2wMlA3OzRzIN88US=>NGXW[oNUSU6JRWK=
SU-DHL-1NV:4ZVhyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYPJR|UxRTBwME[zO|kh|ryPM4LuVXNCVkeHUh?=
NCI-H719NGS2O3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVPJR|UxRTBwMEe4PFgh|ryPNE[xNodUSU6JRWK=
MLMAMY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1Xy[GlEPTB;MD6wPVA3KM7:TR?=NWjCSXJiW0GQR1XS
KM12MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGe2d3FKSzVyPUCuNFk4OzdizszNMmDvV2FPT0WU
SUP-T1NVTlNXBlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmDmTWM2OD1yLkC5PVgzKM7:TR?=NWfGW2N4W0GQR1XS
MZ1-PCMmfuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3O1[2lEPTB;MD6xNVM{PiEQvF2=NYTvTmtHW0GQR1XS
MFE-296MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkjkTWM2OD1yLkGxPFM6KM7:TR?=MX7TRW5ITVJ?
ALL-PONWSw[WhtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mnf4TWM2OD1yLkGyOFQ{KM7:TR?=MnXoV2FPT0WU
GB-1M4Xqemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYjJR|UxRTBwMUK1NVIh|ryPNFfBS5NUSU6JRWK=
SIG-M5NF;CSZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn3RTWM2OD1yLkGzN|ch|ryPNYTOUnFHW0GQR1XS
P30-OHKNH76NpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXnLSVY5UUN3ME2wMlE2Pjd{IN88US=>NHLRfJhUSU6JRWK=
NCI-H716M3PCN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFXxU5hKSzVyPUCuNVYzPjZizszNNWjKNFF{W0GQR1XS
MPP-89NIDyZ2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlXTTWM2OD1yLkG2PVM{KM7:TR?=NXvvOVVzW0GQR1XS
SF126NYLxSWR{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYH5OGF{UUN3ME2wMlE4ODZ|IN88US=>NIj6dJFUSU6JRWK=
CTB-1Mo\aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mlz6TWM2OD1yLkG3N|E3KM7:TR?=M2X0TXNCVkeHUh?=
CA46MoGwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3fMNmlEPTB;MD6xO|Q5QSEQvF2=MYLTRW5ITVJ?
NCI-H520MnLNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRTBwMUe3N|Ih|ryPMmT3V2FPT0WU
CAL-85-1MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MknXTWM2OD1yLkG3PVI4KM7:TR?=NYTNSYV[W0GQR1XS
NCI-H2342NWnSN|ZqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTBwMUi1O|ch|ryPM{XkcnNCVkeHUh?=
697NHnWbIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlPtTWM2OD1yLkG4PFcyKM7:TR?=NInoWZBUSU6JRWK=
NYNXTx[IpXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MonBTWM2OD1yLkG5Nlg4KM7:TR?=M1L1VHNCVkeHUh?=
T98GMn;jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3TTeGlEPTB;MD6xPVMyQCEQvF2=M1T3dnNCVkeHUh?=
NCI-H1703MoXES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkHmTWM2OD1yLkG5OlE2KM7:TR?=NFzkW2dUSU6JRWK=
NCI-H2087NF[yS2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXjBdnhJUUN3ME2wMlIxPDN7IN88US=>MnX6V2FPT0WU
PF-382MoXBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoLtTWM2OD1yLkKwPFc{KM7:TR?=M3rGdHNCVkeHUh?=
HCT-116M4LxZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlewTWM2OD1yLkKxNFY6KM7:TR?=NHK0UJVUSU6JRWK=
CAKI-1M3X5bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1\zSGlEPTB;MD6yNVY3PiEQvF2=M1focXNCVkeHUh?=
CCF-STTG1MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTBwMkK0O|Uh|ryPNEi1Z5ZUSU6JRWK=
D-392MGM3\Oc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{K1NmlEPTB;MD6yN|E4PyEQvF2=M1K0cHNCVkeHUh?=
RT-112MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3zsS2lEPTB;MD6yN|c6PSEQvF2=MWnTRW5ITVJ?
MES-SAM3\aZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXLvOVFMUUN3ME2wMlI1OTh5IN88US=>MmHoV2FPT0WU
LC-2-adNXvZTINyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2nJR2lEPTB;MD6yOFI3PSEQvF2=NF3zUXJUSU6JRWK=
NOS-1M17idWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4ezXmlEPTB;MD6yOFM3PyEQvF2=MkS4V2FPT0WU
NALM-6M3LRSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmflTWM2OD1yLkK1OVQ{KM7:TR?=NFzS[YVUSU6JRWK=
TE-15M4XiSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2i5SWlEPTB;MD6yOlA6OSEQvF2=NETnb5hUSU6JRWK=
786-0NUjXTIlFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVTWPZFLUUN3ME2wMlI3OjJ6IN88US=>M1juNHNCVkeHUh?=
IST-MES1MmHsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzjcGZKSzVyPUCuNlY5OjlizszNMYjTRW5ITVJ?
KYSE-180NVrqUnNRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWLiR3U{UUN3ME2wMlI3QDlzIN88US=>NF;uXo9USU6JRWK=
YTMonwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXG1V3NwUUN3ME2wMlI3QTd2IN88US=>MV3TRW5ITVJ?
A427Mm\aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEnwNnlKSzVyPUCuNlczPjRizszNNYrTWXhHW0GQR1XS
KYSE-450MlewS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWDJR|UxRTBwMkezNlkh|ryPMkP2V2FPT0WU
HuH-7NUizTYRsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTBwMke3OlMh|ryPNFTYPXNUSU6JRWK=
CAS-1MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGjrfpZKSzVyPUCuNlg{ODNizszNMUXTRW5ITVJ?
KURAMOCHINEXvT3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVHOUIhOUUN3ME2wMlI5PDF7IN88US=>MkKwV2FPT0WU
ACHNMV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1GzTmlEPTB;MD6yPVMzOyEQvF2=MkjHV2FPT0WU
HGC-27NWXZS2dPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4HsTGlEPTB;MD6yPVM2OyEQvF2=NUTBbWlwW0GQR1XS
A172M3G5Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEDQXY1KSzVyPUCuNlk2PzdizszNM2m5OXNCVkeHUh?=
SNU-449NEDTVotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF3NbmFKSzVyPUCuNlk6PjRizszNMkTsV2FPT0WU
SW982MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHv3ZYRKSzVyPUCuNlk6PzhizszNNUW2SGFNW0GQR1XS
EFO-21M{DSe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIn3THpKSzVyPUCuN|A1OTFizszNM1;NXHNCVkeHUh?=
NCI-H2030MnXkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4TjcWlEPTB;MD6zNVE3PCEQvF2=NUfRR|VRW0GQR1XS
HT-144MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVLJPWh7UUN3ME2wMlMyOjhizszNNUP6SZIzW0GQR1XS
MFE-280NGrKcW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoLYTWM2OD1yLkOxOFU{KM7:TR?=NHnwcXRUSU6JRWK=
SK-LU-1NVXNVHdGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFLzOmtKSzVyPUCuN|E1PjZizszNMYnTRW5ITVJ?
NCI-H2052NH7ZWJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3POU2lEPTB;MD6zNVQ5PCEQvF2=M2ewfHNCVkeHUh?=
SK-HEP-1NYDZ[XNIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkjhTWM2OD1yLkOzN|Y5KM7:TR?=NX;vNpRiW0GQR1XS
QIMR-WILMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH;KZ3pKSzVyPUCuN|M1OjRizszNMXTTRW5ITVJ?
A2780NF\JcVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4LrT2lEPTB;MD6zOFMxPCEQvF2=NV\nW25UW0GQR1XS
ACNNYfhe3d3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV;JR|UxRTBwM{S4O|Mh|ryPMYPTRW5ITVJ?
BxPC-3Mn[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3r1RmlEPTB;MD6zOFk5QSEQvF2=NGLkSVFUSU6JRWK=
BCPAPM2rGWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTBwM{[wNFEh|ryPM3q3OXNCVkeHUh?=
HOP-62Ml;ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7JR|UxRTBwM{[xNFYh|ryPNHjFSIlUSU6JRWK=
SW1710NVvDXFAxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVv4cpF3UUN3ME2wMlM3PDV3IN88US=>MYrTRW5ITVJ?
OPM-2M{LoSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmLiTWM2OD1yLkO2OFc{KM7:TR?=NGnzdnBUSU6JRWK=
DBTRG-05MGNGH2SI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3myWWlEPTB;MD6zPFA2PCEQvF2=NFvydW1USU6JRWK=
SK-MEL-24M3zLbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NELYfnlKSzVyPUCuN|k4QTFizszNM{PQNXNCVkeHUh?=
8305CNHnGUHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnHaTWM2OD1yLkO5O|k{KM7:TR?=Mo\jV2FPT0WU
OVCAR-4MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkPkTWM2OD1yLkSxOVg3KM7:TR?=NEfKZ5VUSU6JRWK=
HLEMn7BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3n1VWlEPTB;MD60NVg3KM7:TR?=NV7pbpVsW0GQR1XS
NCI-H747M1H5V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1\4fWlEPTB;MD60NlE{PyEQvF2=Mn[5V2FPT0WU
SW780MkXnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVvJR|UxRTBwNEKzOFYh|ryPMmToV2FPT0WU
KYSE-150M{P3bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmW3TWM2OD1yLkSyOFE2KM7:TR?=NYGyTXY{W0GQR1XS
H4NELKSJVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4S2b2lEPTB;MD60NlQ2OSEQvF2=MUjTRW5ITVJ?
SW1088NELhWHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUPBVYd5UUN3ME2wMlQ1OzlizszNMnjqV2FPT0WU
SF268NXrFPJdJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXnJR|UxRTBwNES4OkDPxE1?NEO4ephUSU6JRWK=
RT4MmX6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGPxTJpKSzVyPUCuOFUyOTFizszNM3qxcnNCVkeHUh?=
NCI-H522NFz5[YJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4PRUmlEPTB;MD60OVI4KM7:TR?=M37rSHNCVkeHUh?=
LCLC-97TM1M1nvSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoHiTWM2OD1yLkS2NVk2KM7:TR?=M1zzcXNCVkeHUh?=
CAL-39MnTzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3na[GlEPTB;MD60OlUyQSEQvF2=MnThV2FPT0WU
CAL-120M4nYbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXLjV3lYUUN3ME2wMlQ4PjR|IN88US=>NFO0dndUSU6JRWK=
ESS-1MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIruT5hKSzVyPUCuOFc5OjFizszNNYPJXYFRW0GQR1XS
KARPAS-45NHjkWHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWnJR|UxRTBwNEi5N|Mh|ryPM3nNS3NCVkeHUh?=
DU-4475Mn:5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV;JR|UxRTBwNEm1NVEh|ryPMkH5V2FPT0WU
VMRC-RCZMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYrJR|UxRTBwNEm5NFQh|ryPNWXGb3NDW0GQR1XS
HOSMoDXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUPEbmxHUUN3ME2wMlUxOzZ3IN88US=>NUjBTIJqW0GQR1XS
MOLT-16M1PyXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTBwNUG4NFgh|ryPMXLTRW5ITVJ?
RPMI-6666M{TuO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYfG[XNmUUN3ME2wMlUzOTN3IN88US=>MXPTRW5ITVJ?
K052M2K1Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWfJR|UxRTBwNUKxOEDPxE1?NWC1OZE6W0GQR1XS
EHEBM{f2cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRTBwNUKxPFIh|ryPMUHTRW5ITVJ?
MFH-inoMUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4XOOWlEPTB;MD61NlM2OSEQvF2=M37MbHNCVkeHUh?=
A4-FukNXHPdIxFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGj3cYdKSzVyPUCuOVI2OjhizszNMVTTRW5ITVJ?
SW1417MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTBwNUK3PFEh|ryPNInGdWtUSU6JRWK=
DoTc2-4510M2XsfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{TJPGlEPTB;MD61OFk2QCEQvF2=M4P2PXNCVkeHUh?=
TE-12MornS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXvJR|UxRTBwNUW3N|Uh|ryPMkXMV2FPT0WU
8-MG-BANWnpNlVnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmnYTWM2OD1yLkW2NFU3KM7:TR?=NHzmS|dUSU6JRWK=
ECC12NUDBU5V4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH3h[nlKSzVyPUCuOVY2PThizszNNUf0ZnV4W0GQR1XS
CHL-1MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3zabWlEPTB;MD61O|Q3OyEQvF2=NULrVZNtW0GQR1XS
LCLC-103HMl3jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1jMPWlEPTB;MD61PFM1PCEQvF2=NUnGNVdTW0GQR1XS
OS-RC-2NVPabVB1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{Hue2lEPTB;MD61PFM4QSEQvF2=MYjTRW5ITVJ?
RO82-W-1M13OfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmrrTWM2OD1yLkW5OlE2KM7:TR?=M2fpU3NCVkeHUh?=
A3-KAWNXjsTnJET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWfJR|UxRTBwNkG0Olch|ryPM{W4cXNCVkeHUh?=
NCCITMlzPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoHDTWM2OD1yLk[xO|E2KM7:TR?=M3L4dnNCVkeHUh?=
IST-SL2NVizeHl4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkjSTWM2OD1yLk[yOVIzKM7:TR?=MXrTRW5ITVJ?
GI-ME-NNI\PXJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NES2PWdKSzVyPUCuOlMxPjlizszNMlvDV2FPT0WU
ES6NID4VYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX\MNFlYUUN3ME2wMlY{Ojl3IN88US=>NWHI[3NvW0GQR1XS
BL-41MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1:x[WlEPTB;MD62N|M2OiEQvF2=M3fkOHNCVkeHUh?=
Ca-SkiNH20dXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVnq[XQ6UUN3ME2wMlY1QDFizszNNWfXeFRmW0GQR1XS
HOP-92M3ywOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTlNG13UUN3ME2wMlY2Pjd{IN88US=>NEfsXWdUSU6JRWK=
SK-LMS-1NVrBT44yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4XhdGlEPTB;MD62OlQ4KM7:TR?=M1HoXXNCVkeHUh?=
EW-13NWHKPFRFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVLiOpU5UUN3ME2wMlY3Pzd7IN88US=>MWHTRW5ITVJ?
647-VNFTkepVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXjab|h[UUN3ME2wMlY5OTR6IN88US=>NFXRXo5USU6JRWK=
JiyoyeP-2003NGi4SFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkjZTWM2OD1yLk[5O|M5KM7:TR?=NUXm[WNUW0GQR1XS
WSU-NHLNUW2bmQ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4jtR2lEPTB;MD63NFg5PyEQvF2=MWTTRW5ITVJ?
U-698-MNELtPWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXfnZWRrUUN3ME2wMlcyODZ|IN88US=>Mmj3V2FPT0WU
HC-1NW\EVWJlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXvq[YdiUUN3ME2wMlczPDB3IN88US=>MYLTRW5ITVJ?
8505CNX61dnBrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIjlb|JKSzVyPUCuO|I4PDFizszNNX7lTZdWW0GQR1XS
HUTU-80NVK5XG5iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1;Tc2lEPTB;MD63N|M1QSEQvF2=NGH0VIZUSU6JRWK=
LB1047-RCCM1zHfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mmq1TWM2OD1yLkezOVM5KM7:TR?=M2G3T3NCVkeHUh?=
GAMGNEfJbpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH;kUYFKSzVyPUCuO|M3PTNizszNM1nwfnNCVkeHUh?=
CAL-12TMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M372VmlEPTB;MD63N|g4PyEQvF2=NYTNN3JzW0GQR1XS
NCI-SNU-1M{jHfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlP6TWM2OD1yLke3Nlc5KM7:TR?=MoiwV2FPT0WU
HTC-C3Mn[0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzLNHVKSzVyPUCuO|c1PTFizszNNYXLO3l3W0GQR1XS
HPAF-IINIK2fY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3vRfGlEPTB;MD63O|UxOSEQvF2=M2\FR3NCVkeHUh?=
KGNMYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NInsSpBKSzVyPUCuO|gxQDFizszNM3i5fnNCVkeHUh?=
EFO-27NIWwZnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF;NS2hKSzVyPUCuO|g4OzNizszNM{DaTXNCVkeHUh?=
MEL-HOMoXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mo[0TWM2OD1yLke5OFQ6KM7:TR?=MY\TRW5ITVJ?
KYSE-270NXy4SJZXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGPRS3VKSzVyPUCuPFA2OjlizszNNW[0fnBOW0GQR1XS
NCI-H1755NUTY[ldIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmjlTWM2OD1yLkiwO|E1KM7:TR?=M2D0U3NCVkeHUh?=
MFM-223NVLQ[|dxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3ju[2lEPTB;MD64NVQxPyEQvF2=MU\TRW5ITVJ?
G-361NHHxVJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV7KSlluUUN3ME2wMlgyQDl5IN88US=>MkfpV2FPT0WU
ETK-1Ml3QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4fEcGlEPTB;MD64NlQ1OSEQvF2=MWPTRW5ITVJ?
LU-99AMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzUSWhwUUN3ME2wMlg1PzBzIN88US=>NGHyVmpUSU6JRWK=
IST-MEL1MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGHnOJBKSzVyPUCuPFU4OzJizszNMmTkV2FPT0WU
L-540M{fCT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml7MTWM2OD1yLki1PFAyKM7:TR?=M4n2dnNCVkeHUh?=
U-2-OSNEnQSGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIrq[WVKSzVyPUCuPFU5PDZizszNNYnmTZZjW0GQR1XS
HT-1376Ml7ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUDQ[|NMUUN3ME2wMlg3ODVzIN88US=>M2roPXNCVkeHUh?=
COLO-680NMkXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NETneIFKSzVyPUCuPFc6OzNizszNMmHBV2FPT0WU
NCI-H1581MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3\tV2lEPTB;MD64PVI6PyEQvF2=M4rzPHNCVkeHUh?=
HuCCT1MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn7FTWM2OD1yLki5OVQ5KM7:TR?=MlPtV2FPT0WU
BB30-HNCNUHRNmNtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF;2eFdKSzVyPUCuPVI1PjlizszNMoHPV2FPT0WU
NCI-H2347NYPie29kT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTBwOUOyPVIh|ryPM4nhUnNCVkeHUh?=
G-401Ml;HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXjJR|UxRTBwOUO2PVUh|ryPMU\TRW5ITVJ?
NCI-H358NE\5OG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWLsNHd[UUN3ME2wMlk2ODF2IN88US=>MVvTRW5ITVJ?
HCC1395MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnPNTWM2OD1yLkm1OFYyKM7:TR?=MXvTRW5ITVJ?
J82MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoXXTWM2OD1yLkm1OVQ{KM7:TR?=M3r0XnNCVkeHUh?=
KE-37MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4nKRmlEPTB;MD65OlM5PyEQvF2=M{nufnNCVkeHUh?=
NOMO-1MkT0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{\YVWlEPTB;MD65OlU3PCEQvF2=MlmyV2FPT0WU
ML-2MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnnWTWM2OD1yLkm5O|Uh|ryPM4rseXNCVkeHUh?=
SW872NFe3U3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEHQUJNKSzVyPUCuPVk4PzVizszNNImySpNUSU6JRWK=
KYSE-520NHz6U5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIXxN3dKSzVyPUGuNFA1QTRizszNNXTtR|BUW0GQR1XS
HL-60NFXVXVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF3PbpNKSzVyPUGuNFA6PyEQvF2=NWfQe4dxW0GQR1XS
HDLM-2MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2XsWmlEPTB;MT6wNVI2OiEQvF2=NV\FOoJjW0GQR1XS
MIA-PaCa-2NHLFZm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkXvTWM2OD1zLkCxN|c2KM7:TR?=M1\0W3NCVkeHUh?=
TCCSUPNH7he|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3;rd2lEPTB;MT6wNVc{OiEQvF2=NIjWNoJUSU6JRWK=
SH-4NYjiOmt3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3zoO2lEPTB;MT6wNlI1PCEQvF2=MmLoV2FPT0WU
MG-63NH\RXY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXPzN4t5UUN3ME2xMlAzPjF4IN88US=>Mk\WV2FPT0WU
NB6M2DJ[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVnJR|UxRTFwMEOxNFkh|ryPNUHwU2J1W0GQR1XS
CAL-54M33vcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH;Se2pKSzVyPUGuNFM6PTlizszNMUHTRW5ITVJ?
DU-145MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlT6TWM2OD1zLkC4NFc{KM7:TR?=M4q0bnNCVkeHUh?=
HCE-4MljlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkfwTWM2OD1zLkC5Nlg3KM7:TR?=M1zPd3NCVkeHUh?=
U-266MoTKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml;XTWM2OD1zLkC5OlM{KM7:TR?=NU[4e2x{W0GQR1XS
HT-1197NYLI[lQ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkL6TWM2OD1zLkGxOFM5KM7:TR?=MlvDV2FPT0WU
EW-1NVnjd4ZrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFnXZ3ZKSzVyPUGuNVQyOjhizszNNYHhemZNW0GQR1XS
MHH-NB-11MonGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{DRXmlEPTB;MT6xOVM3QCEQvF2=MXLTRW5ITVJ?
NCI-H2405NXLYR|c1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4HqWWlEPTB;MT6xOlE3KM7:TR?=Mon2V2FPT0WU
COLO-668MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHVTWM2OD1zLkG2OFkh|ryPM4f5WnNCVkeHUh?=
IMR-5NVH3d3lET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH\NcmdKSzVyPUGuNVY6OzZizszNMXnTRW5ITVJ?
ARH-77NYHvXZd3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkfsTWM2OD1zLkKyPVI1KM7:TR?=NGjRe5VUSU6JRWK=
BHT-101NYTPbIdTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1rNRmlEPTB;MT6yN|Q6KM7:TR?=NGjPZ2VUSU6JRWK=
SCC-25NVTBVW1lT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{LURmlEPTB;MT6yN|U{PiEQvF2=MWjTRW5ITVJ?
NTERA-S-cl-D1Mn\ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2\uc2lEPTB;MT6yOFM1PiEQvF2=M{PzWHNCVkeHUh?=
MKN28NXfkT24yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWf6PG5CUUN3ME2xMlI2PjN4IN88US=>NIXlemJUSU6JRWK=
KS-1NUPFXGhnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1jCU2lEPTB;MT6yPFI3QSEQvF2=NFLKUndUSU6JRWK=
NCI-H1734NX73TZpXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M13QUmlEPTB;MT6yPFkyOyEQvF2=MkexV2FPT0WU
ES7NInIbYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmHLTWM2OD1zLkK5OVQzKM7:TR?=Mk\QV2FPT0WU
NCI-H838NITPXo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MknLTWM2OD1zLkOwOlE2KM7:TR?=MV\TRW5ITVJ?
HEC-1MlfES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M37TSGlEPTB;MT6zN|c2PSEQvF2=NVzPTGx7W0GQR1XS
ME-180NES0bWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoDPTWM2OD1zLkO3PVk{KM7:TR?=MnPjV2FPT0WU
MMAC-SFNYfxRoFXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV74fm1MUUN3ME2xMlM6PTl3IN88US=>M{TpfXNCVkeHUh?=
IA-LMMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkXETWM2OD1zLkSwPVE1KM7:TR?=NILCXYlUSU6JRWK=
MN-60M2jrUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn6yTWM2OD1zLkSzNVE1KM7:TR?=NFn3PJhUSU6JRWK=
SIMAM33WOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnzHTWM2OD1zLkS4Olg4KM7:TR?=NETUS4VUSU6JRWK=
NCI-H1770MofTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHjWNpdKSzVyPUGuOVIxPTRizszNNHHvdnNUSU6JRWK=
ONS-76NHHGXXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mlv2TWM2OD1zLkWyN|EyKM7:TR?=NVuzd|MzW0GQR1XS
LB771-HNCM3j1VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH\TdYdKSzVyPUGuOVM6ODZizszNNHHXd|dUSU6JRWK=
SW48NGTpV3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXfMSWU5UUN3ME2xMlU1OjR|IN88US=>Mn61V2FPT0WU
KYSE-140MlTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEe2OGpKSzVyPUGuOVU4PDFizszNNGn5SWFUSU6JRWK=
SW626NVX5dVFnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWezfnBNUUN3ME2xMlU5OTZizszNNGTZXYFUSU6JRWK=
MC-CARNWn4RWFUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVXtXGx1UUN3ME2xMlU5PjZ|IN88US=>NIPCRW1USU6JRWK=
D-336MGMlizS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnfRTWM2OD1zLk[yPVQh|ryPM2joXHNCVkeHUh?=
SK-MEL-3M1Xi[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHrqOohKSzVyPUGuOlM6ODJizszNNXr3[Zc6W0GQR1XS
MHH-PREB-1MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYrJR|UxRTFwNkS0O|Mh|ryPMXTTRW5ITVJ?
Calu-1NX\hdFBlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVjJR|UxRTFwNkWzPFYh|ryPM2jZTHNCVkeHUh?=
HCC1806M1zTSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTPVVV{UUN3ME2xMlY3PjFzIN88US=>MofvV2FPT0WU
A101DNX7nVGVOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIDSXoZKSzVyPUGuOlY4QDFizszNMoj6V2FPT0WU
A704NGHhNY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGHPOXZKSzVyPUGuOlg{OTFizszNM3uz[HNCVkeHUh?=
LB831-BLCNVnobJE2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M36z[2lEPTB;MT62PVg2PCEQvF2=NYHOPIV2W0GQR1XS
RL95-2MoLHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVHuWolkUUN3ME2xMlcyPDZ|IN88US=>MXfTRW5ITVJ?
RPMI-2650MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXfJR|UxRTFwN{K3NVkh|ryPMW\TRW5ITVJ?
NH-12MmDKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MofLTWM2OD1zLkezOFI4KM7:TR?=M2rOb3NCVkeHUh?=
AGSMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYLJR|UxRTFwN{[zOVgh|ryPM{\1XnNCVkeHUh?=
NEC8MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M16xWGlEPTB;MT63PFk6PSEQvF2=Mo\FV2FPT0WU
NCI-H2009MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHm3U3dKSzVyPUGuO|k4OjFizszNMWjTRW5ITVJ?
A498NHeyVHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2\NRWlEPTB;MT64NVI5OiEQvF2=NVzvZYNKW0GQR1XS
NCI-H810MlnKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHG4NVhKSzVyPUGuPFE3ODZizszNMmDEV2FPT0WU
SK-NEP-1NEHqOXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEj3eI5KSzVyPUGuPFM4PjdizszNNH\udmFUSU6JRWK=
D-542MGMoP2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmrQTWM2OD1zLki1PFUyKM7:TR?=NVXPOINRW0GQR1XS
KNS-42MlHnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4L4Z2lEPTB;MT64OlI3PiEQvF2=M1f2THNCVkeHUh?=
NCI-H2452NFPBW|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmDVTWM2OD1zLki5NFc1KM7:TR?=NYfmVXVoW0GQR1XS
SK-MEL-2NW\RXpZJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlHQTWM2OD1zLkmwNlcyKM7:TR?=MmjmV2FPT0WU
OVCAR-5MkXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEW5cGlKSzVyPUGuPVA3PzVizszNNGDpO2JUSU6JRWK=
SNG-MMn7WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUjJR|UxRTFwOUW4OVgh|ryPMlnUV2FPT0WU
A673M1\6fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\2TWM2OD1zLkm3OVE3KM7:TR?=NIXOcHRUSU6JRWK=
L-428NHzvTm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFm0ZmFKSzVyPUGuPVkyPzlizszNMYfTRW5ITVJ?
KM-H2NGfWZmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1vzWWlEPTB;Mj6wNVA6KM7:TR?=MV\TRW5ITVJ?
MC-IXCM13VXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYHJR|UxRTJwMEKyO|Mh|ryPNFj0SndUSU6JRWK=
COLO-678Mn\qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1HafWlEPTB;Mj6wOFIxPyEQvF2=MXnTRW5ITVJ?
MEL-JUSONWrLZVVvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFG0OIlKSzVyPUKuNFc5PTFizszNMo\UV2FPT0WU
HCC38NH6wfZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnfGTWM2OD1{LkC4OFM{KM7:TR?=M{\0c3NCVkeHUh?=
UACC-62M3G3ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYHSdoFkUUN3ME2yMlA5QDV3IN88US=>NHfwOmdUSU6JRWK=
OAW-42MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWi4d|N4UUN3ME2yMlA6PzFzIN88US=>MUTTRW5ITVJ?
LB996-RCCMWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTJwMUO4NVch|ryPNVLyUZcyW0GQR1XS
COR-L105NYnjNXZuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTJwMU[zO|Mh|ryPMl;6V2FPT0WU
RCC10RGBM2TGOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGW1[2JKSzVyPUKuNVg2PzZizszNNIDL[XVUSU6JRWK=
A431MnLFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn\mTWM2OD1{LkG5NFE6KM7:TR?=NWPYXnlFW0GQR1XS
NCI-H292NILZRZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTJwMkO5OVEh|ryPNG\kb5ZUSU6JRWK=
SK-UT-1NEPaOnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnPwTWM2OD1{LkOzNVg1KM7:TR?=MVTTRW5ITVJ?
PANC-08-13M2LZTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX;JR|UxRTJwM{OyN|Uh|ryPM3TDTnNCVkeHUh?=
ST486NYP4fWVlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXXHZpU6UUN3ME2yMlQyODR6IN88US=>M2XSU3NCVkeHUh?=
SJSA-1M1TDWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYrJR|UxRTJwNEGyO|Eh|ryPMV;TRW5ITVJ?
RKOM2X3W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYTCem5YUUN3ME2yMlQzODJ7IN88US=>MljUV2FPT0WU
NCI-H1793MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3TISWlEPTB;Mj60OFAzQSEQvF2=MUnTRW5ITVJ?
639-VMkTiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHLZU21KSzVyPUKuOFU{QDJizszNMkLFV2FPT0WU
ES3MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWLJR|UxRTJwNEm3N|ch|ryPMWDTRW5ITVJ?
NCI-H1792NIi2TldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{npOGlEPTB;Mj61OlgzPiEQvF2=NYL1TIg3W0GQR1XS
NCI-H1651MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2TEdmlEPTB;Mj61PFIyKM7:TR?=NGPkNpRUSU6JRWK=
SN12CM3PCWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIHYZ5RKSzVyPUKuOVg1QDdizszNM4PGR3NCVkeHUh?=
COLO-679NWPO[G1RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NU\wSXcyUUN3ME2yMlU5PjB3IN88US=>NXy1Omk2W0GQR1XS
U-118-MGNUCxTIRTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHKxTodKSzVyPUKuOVg5PzJizszNMYLTRW5ITVJ?
Ramos-2G6-4C10MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH3jU21KSzVyPUKuOlQ5ODdizszNNYq3S49QW0GQR1XS
HCT-15NHzlSlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVHYc|hFUUN3ME2yMlY5Pzl{IN88US=>NGXXR2FUSU6JRWK=
MDA-MB-157MmXnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX3WWolJUUN3ME2yMlcxPzR5IN88US=>M{\5PXNCVkeHUh?=
K5MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUDJR|UxRTJwN{G4OFUh|ryPNIjiXmhUSU6JRWK=
MKN45Mn;rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH71dGlKSzVyPUKuO|M{PjZizszNMWTTRW5ITVJ?
DMS-273Mm\xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH70SmtKSzVyPUKuO|U3OzJizszNMoXMV2FPT0WU
C8166M{LPXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGm2fGZKSzVyPUKuO|g2OTNizszNM1rRWHNCVkeHUh?=
Calu-3NGPzR2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUPLcWtXUUN3ME2yMlc5QTZ7IN88US=>MnzFV2FPT0WU
SNB75NYmxOJBiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3nrTWlEPTB;Mj64PFU{PSEQvF2=NXvaNVR[W0GQR1XS
BFTC-905MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mme0TWM2OD1{LkmwNVkyKM7:TR?=MXTTRW5ITVJ?
C-4-IIM4rsSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\qWGlEPTB;Mj65NVM2OyEQvF2=MmPJV2FPT0WU
MS-1M3PoS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEDCe4RKSzVyPUKuPVY4PjlizszNM1HJOXNCVkeHUh?=
A375NV\SO|NVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPnTWM2OD1|LkC4NVg1KM7:TR?=NF\aToZUSU6JRWK=
KYSE-70MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlLUTWM2OD1|LkC4PFgzKM7:TR?=MYTTRW5ITVJ?
KYSE-510MkLIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1:xfmlEPTB;Mz6xNFk6PSEQvF2=NYDte|h5W0GQR1XS
LN-405NU\3PZFYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWDJR|UxRTNwMUO1NVgh|ryPNEjKcW9USU6JRWK=
BOKUNYno[IVyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGLtPJVKSzVyPUOuNVQzPTZizszNNH7XWHlUSU6JRWK=
TE-10NITqNWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlrZTWM2OD1|LkG3N|YzKM7:TR?=NX\Y[5lRW0GQR1XS
MKN1NHrYSoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4f5WWlEPTB;Mz6xPFQ5OyEQvF2=M3G1OXNCVkeHUh?=
M059JNVfTfpkxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NInScZFKSzVyPUOuNlAyPzNizszNNEDScGdUSU6JRWK=
GOTOMkfmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVzJR|UxRTNwMkKwN|kh|ryPNV3vcJhjW0GQR1XS
DK-MGMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIDlTIdKSzVyPUOuNlU6PzZizszNNG[0[2RUSU6JRWK=
NCI-H727NXG4VW5pT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHnNfJBKSzVyPUOuNlY2QCEQvF2=NH[yR4hUSU6JRWK=
NB12NVrLVVhVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRTNwM{OyNlQh|ryPNULjOYRZW0GQR1XS
DOKNF73e|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIfidopKSzVyPUOuN|YyQDZizszNMWHTRW5ITVJ?
KYSE-410MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTNwM{[yPFch|ryPM{TNd3NCVkeHUh?=
AM-38NInZd3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mke3TWM2OD1|LkO4NFUyKM7:TR?=NGL4[GdUSU6JRWK=
GR-STMlqxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1j3ZmlEPTB;Mz60OVc{OiEQvF2=MUnTRW5ITVJ?
D-247MGNW\DT3N1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnfDTWM2OD1|LkS4NlY{KM7:TR?=M{[5c3NCVkeHUh?=
TE-8MlO1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXLJR|UxRTNwNEmzN|Mh|ryPMl\zV2FPT0WU
LS-411NMknWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTNwNEm2PVIh|ryPMX\TRW5ITVJ?
SK-MES-1MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkDCTWM2OD1|LkW2OFM{KM7:TR?=MYDTRW5ITVJ?
SF295MnHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVjudJBPUUN3ME2zMlYyPTV{IN88US=>M1y3O3NCVkeHUh?=
SK-MEL-30MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlLXTWM2OD1|Lk[1PVIyKM7:TR?=NWLzUI9nW0GQR1XS
LB2241-RCCNGXqe49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVjBcYozUUN3ME2zMlY3OjZizszNNGewW|lUSU6JRWK=
PC-14MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX20cIZYUUN3ME2zMlY3PDN5IN88US=>NVzYOWh2W0GQR1XS
EW-7NWDySGNbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV7JR|UxRTNwNke2PVMh|ryPMoHtV2FPT0WU
NMC-G1NYq4O5NrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{Hlc2lEPTB;Mz63NVg{PyEQvF2=MnLLV2FPT0WU
TE-441-TMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWnJR|UxRTNwN{OwNlgh|ryPNF7VfpZUSU6JRWK=
NCI-H1618NVj6O2w4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXSzfnZEUUN3ME2zMlgyQDd3IN88US=>MUPTRW5ITVJ?
PANC-03-27M1vCT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIrPc2VKSzVyPUOuPFE6OTZizszNNFXyfmhUSU6JRWK=
NCI-H2228NYLtSHQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M17DSmlEPTB;Mz64N|EzPiEQvF2=NYjPR2pmW0GQR1XS
CAPAN-1Mne5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlGzTWM2OD1|Lki3NFA6KM7:TR?=MVjTRW5ITVJ?
KLEMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{\tVGlEPTB;Mz65NFY4KM7:TR?=NVvZU2luW0GQR1XS
BeckerM3;PTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTNwOUK4OFkh|ryPNEHlfFNUSU6JRWK=
SK-PN-DWNULzb|FsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXXJR|UxRTRwMEe5O|Qh|ryPNWfH[|B{W0GQR1XS
Hs-578-TM{L1fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXvObpl{UUN3ME20MlA5OzB4IN88US=>MYHTRW5ITVJ?
RS4-11MmjUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoLLTWM2OD12LkGxNlU2KM7:TR?=NVrreYFbW0GQR1XS
D-502MGNYjuTHhqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2fpPWlEPTB;ND6xOlk6PyEQvF2=NXrrXVJJW0GQR1XS
GI-1MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mny4TWM2OD12LkK4Nlk6KM7:TR?=NWrFPFI2W0GQR1XS
NCI-H209M2fGWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVHJR|UxRTRwM{O3PEDPxE1?NF\GUoxUSU6JRWK=
SK-OV-3M4GzR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{fpSWlEPTB;ND60PFE1QSEQvF2=NHfuRYdUSU6JRWK=
LOUCYNI[3bG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX20T3FxUUN3ME20MlQ5PDN{IN88US=>NImwfHdUSU6JRWK=
NCI-H69NFL4cpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWnSc|dlUUN3ME20MlUyPzl|IN88US=>MmPaV2FPT0WU
SCC-9MkjKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTRwNUOxO|Ih|ryPM4jqc3NCVkeHUh?=
NCI-H526M4G5XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3vB[mlEPTB;ND61PVI6OyEQvF2=MXzTRW5ITVJ?
NCI-H2170MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXXJR|UxRTRwNk[3O|Eh|ryPM{jUcHNCVkeHUh?=
SRM3rxe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV;SXJNSUUN3ME20MlcxODR6IN88US=>NXnDcGo{W0GQR1XS
CMKMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmDtTWM2OD12LkeyNVAyKM7:TR?=MlX0V2FPT0WU
COLO-829NFXSOolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnvBTWM2OD12Lke3NFQ{KM7:TR?=NWfrV49VW0GQR1XS
HuO-3N1M3uwUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFvVPXhKSzVyPUSuPFMzQDFizszNNGTKVnBUSU6JRWK=
5637NWnmUVhDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mo\NTWM2OD12LkmwOFg4KM7:TR?=NXW2cmlkW0GQR1XS
A253M2X1fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M37iRWlEPTB;ND65O|cxQCEQvF2=NULyeXV4W0GQR1XS
NB10MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{PNVWlEPTB;NT6wO|Q6PyEQvF2=MoTxV2FPT0WU
SF539NUjDSZd6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYPVfVhEUUN3ME21MlA6QTV7IN88US=>M2fQfHNCVkeHUh?=
HAL-01NWnPTJIyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX7qXWVMUUN3ME21MlE1PjR3IN88US=>NUTjUGsxW0GQR1XS
MHH-ES-1Mo\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlnoTWM2OD13LkG2PVI2KM7:TR?=M{\FVnNCVkeHUh?=
DELMn\uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MW\JR|UxRTVwMke1PFIh|ryPMYPTRW5ITVJ?
NCI-H1299Mo[4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF\qN5NKSzVyPUWuN|UxODdizszNNX\6OYlyW0GQR1XS
ChaGo-K-1MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHHMcFhKSzVyPUWuN|UyODdizszNM1joOHNCVkeHUh?=
HMV-IINHPFc3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1S2ZmlEPTB;NT6zPVQ{KM7:TR?=MoPrV2FPT0WU
NB69MlSzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTVwM{m2N|Eh|ryPMknUV2FPT0WU
NCI-H1882MlS4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2\zT2lEPTB;NT60N|M3PCEQvF2=NXz3NphYW0GQR1XS
SNU-475NYm2R4NqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1:4WmlEPTB;NT60O|E4OSEQvF2=M2DGRnNCVkeHUh?=
RXF393NEH4cWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX;JR|UxRTVwNEi0PVQh|ryPNHHKVGtUSU6JRWK=
CAL-51M{\5O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWKycYpCUUN3ME21MlYzQDV|IN88US=>MV7TRW5ITVJ?
SW1573MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX\Cc2VWUUN3ME21MlY{PTN2IN88US=>NWTwXm5sW0GQR1XS
GCTNEey[JJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mke1TWM2OD13Lke1PVI6KM7:TR?=MVzTRW5ITVJ?
COR-L88NFi1NoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWnJR|UxRTVwN{[4OFYh|ryPMmjwV2FPT0WU
MDA-MB-134-VINH\Z[ZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWXJR|UxRTVwOEe1N|Yh|ryPM1v6fXNCVkeHUh?=
NB5NXvmOmRbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGK5fHNKSzVyPUWuPVI1PCEQvF2=NWnJNmI2W0GQR1XS
GMS-10MnO2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHnvZlBKSzVyPUWuPVY5PjFizszNMW\TRW5ITVJ?
CHP-212NXTEXJNQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWHPUWUzUUN3ME22MlQ5OjZ5IN88US=>M2rYWHNCVkeHUh?=
TE-11NFL6SHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX;JR|UxRTZwNUWxPFIh|ryPNVvjPFZVW0GQR1XS
SW962MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYLJR|UxRTZwNkW3O|Qh|ryPMXLTRW5ITVJ?
MZ2-MELMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXL0eppPUUN3ME22MlgzODFzIN88US=>MV\TRW5ITVJ?
C-33-ANFPYU21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml\yTWM2OD14LkmxOlg5KM7:TR?=NE\ObWNUSU6JRWK=
IGR-1NF7HO4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGLHU3dKSzVyPU[uPVc5OjZizszNNYDuVG06W0GQR1XS
MOLT-4MmnsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NInmeHlKSzVyPUeuNVU1ODZizszNM2LUTXNCVkeHUh?=
NCI-H1650MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{W3emlEPTB;Nz6yO|A1PiEQvF2=M4LxNXNCVkeHUh?=
AsPC-1MkLtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4PxUWlEPTB;Nz6yPFYxPSEQvF2=MUDTRW5ITVJ?
SNU-C2BMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXXhcXBmUUN3ME23MlI6PTdzIN88US=>NVjrTnZOW0GQR1XS
MKN7M3nN[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGHsTpNKSzVyPUeuN|czOzVizszNNFHBVoVUSU6JRWK=
SW620MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGDNRllKSzVyPUeuN|gzODVizszNMnezV2FPT0WU
SK-MEL-28M2fHPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVrxdYx5UUN3ME23MlQxPzl6IN88US=>NGjpe3ZUSU6JRWK=
TE-6M3q3bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NETi[pJKSzVyPUeuOFQ6ODhizszNMYDTRW5ITVJ?
D-263MGMm\uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXHybHJ4UUN3ME23MlQ2PzZ{IN88US=>NY\FRW5SW0GQR1XS
NCI-H1355NHnJNVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3PCSmlEPTB;Nz63O|AzQSEQvF2=MmjXV2FPT0WU
DSH1NIDycJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXrJR|UxRTdwN{m3OlIh|ryPM{XXfXNCVkeHUh?=
NCI-H460MkWwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoXwTWM2OD16LkCwOlk1KM7:TR?=NE\uVoRUSU6JRWK=
NCI-H1563MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml7kTWM2OD16LkC3OVA5KM7:TR?=NFXXWY1USU6JRWK=
SW948MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmDDTWM2OD16LkGwO|Q1KM7:TR?=NYPoN3JTW0GQR1XS
LK-2MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYLJR|UxRThwMUK4N|Mh|ryPNIjOc3ZUSU6JRWK=
HT-1080MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmXyTWM2OD16LkGzNVc2KM7:TR?=NGWwbppUSU6JRWK=
NCI-H441M3PRdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MULJR|UxRThwMUmzJO69VQ>?MlLBV2FPT0WU
HSC-4M1;XSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF3ZU|ZKSzVyPUiuNlg4OiEQvF2=MXzTRW5ITVJ?
LXF-289NVL0WVE3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWniN2t7UUN3ME24MlM2QTR|IN88US=>MVnTRW5ITVJ?
MRK-nu-1NWnzRlJWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRThwM{[zNFQh|ryPNU\pU5BOW0GQR1XS
no-11Ml:2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkTDTWM2OD16LkS3NVM{KM7:TR?=M3PMO3NCVkeHUh?=
SNU-387MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MorhTWM2OD16Lk[zNlQ3KM7:TR?=NE\N[41USU6JRWK=
Detroit562MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnO4TWM2OD16Lke1OFU2KM7:TR?=MVLTRW5ITVJ?
SW954MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVnLXopKUUN3ME24Mlc3QDN{IN88US=>M3LFcXNCVkeHUh?=
P12-ICHIKAWAM4XpU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlLLTWM2OD16Lke4PVQh|ryPMnuyV2FPT0WU
TE-9MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkixTWM2OD16LkixNFYzKM7:TR?=NGXWcJVUSU6JRWK=
NB13MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2HB[GlEPTB;OD64N|c6PiEQvF2=NUPNO4M{W0GQR1XS
BPH-1MnTQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmTUTWM2OD16Lki1NFgyKM7:TR?=NUn0NGw3W0GQR1XS
KMOE-2M1HVTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2jK[WlEPTB;OD64O|g6OiEQvF2=M4XkbXNCVkeHUh?=
RPMI-8402NEfDPIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFHnTmFKSzVyPUiuPFk6OjZizszNNWLmWnBNW0GQR1XS
OVCAR-3NWDuNXdsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmO1TWM2OD16Lkm3O|MzKM7:TR?=NHfTXWhUSU6JRWK=
NCI-H2196NFqwSHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVLST4RQUUN3ME24Mlk5PjB4IN88US=>NWDOPYFrW0GQR1XS
MZ7-melNWTNbmpQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MljWTWM2OD17LkCzOFYh|ryPNVTOUpFoW0GQR1XS
GP5dM2nEWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFHITopKSzVyPUmuNFY{OTNizszNMVXTRW5ITVJ?
NCI-N87MmHQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWDwbZlsUUN3ME25MlQ1PzNzIN88US=>NE\NSY1USU6JRWK=
EW-16NUS3PYxtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4XIV2lEPTB;OT60OFg1QCEQvF2=MmHyV2FPT0WU
Calu-6NUG5UmdGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWHYUpFPUUN3ME25MlQ6PzB|IN88US=>MUjTRW5ITVJ?
LC4-1MlXOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUXJR|UxRTlwNkK1O{DPxE1?NVXU[mlUW0GQR1XS
CCRF-CEMNXXNbYhqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4nZOWlEPTB;OT62PFc3PiEQvF2=NIDnS21USU6JRWK=
BC-1NX3QTIx4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3fqNmlEPTB;OT63PFk6KM7:TR?=MmD5V2FPT0WU
NCI-SNU-16M2Oxbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFHYdopKSzVyPUmuO|k1QTVizszNMmXRV2FPT0WU
NCI-H28NV;Ce2FQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXXJR|UxRTlwOES5N|Mh|ryPMnO3V2FPT0WU
SBC-1NFrPSW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEC0PYtKSzVyPUGwMlA4OiEQvF2=NI[xRnJUSU6JRWK=
TURNYTGSVNiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWLJR|UxRTFyLkG2OVch|ryPNFvLeXpUSU6JRWK=
MDA-MB-231NGTtRnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlH5TWM2OD1zMD6yNVE1KM7:TR?=NUCwb5U3W0GQR1XS
C3AM{XDeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTFyLkOxO|kh|ryPMoD2V2FPT0WU
SW1990MoOzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnXzTWM2OD1zMD6zNlgh|ryPMWPTRW5ITVJ?
NCI-H1993NXvheIw3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3\nXGlEPTB;MUCuOVY6OyEQvF2=MnX5V2FPT0WU
SK-CO-1NU\sSYcxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmS4TWM2OD1zMD63O|ch|ryPM1X3UnNCVkeHUh?=
OAW-28MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWLwd5VlUUN3ME2xNE46QDh6IN88US=>M1HVenNCVkeHUh?=
HNMn3hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHjnW4FKSzVyPUGxMlEyOzFizszNM4jwNXNCVkeHUh?=
NCI-H1304M1;zVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnzRTWM2OD1zMT6xOVc3KM7:TR?=MYLTRW5ITVJ?
DaoyM3ywfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{jMSGlEPTB;MUGuOFM{PiEQvF2=Mn;yV2FPT0WU
VA-ES-BJNXH5eVZmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWLMUlVwUUN3ME2xNU44OTl3IN88US=>M{XGNXNCVkeHUh?=
MCF7MoG1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHST2ZKSzVyPUGxMlgyOjZizszNMnz5V2FPT0WU
VM-CUB-1NWLyUYFLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlnDTWM2OD1zMT65NFkyKM7:TR?=MljBV2FPT0WU
IPC-298NHXxVoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIPPVXpKSzVyPUGxMlk{QDNizszNNH62PXpUSU6JRWK=
NCI-H2126NHjWflhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlfZTWM2OD1zMj6wNlE5KM7:TR?=NUPNTooxW0GQR1XS
OVCAR-8MoDXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWLJR|UxRTF{LkGxOFEh|ryPM4\tfnNCVkeHUh?=
SJRH30M{jMSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnTiTWM2OD1zMj6yNlk6KM7:TR?=MnzZV2FPT0WU
DMS-53NE\6cGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MY\JR|UxRTF{LkK2OFkh|ryPNEDxXVJUSU6JRWK=
NCI-H322MMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFjmd|RKSzVyPUGyMlM{PTdizszNM{n1bnNCVkeHUh?=
RVH-421MlPlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{PaZmlEPTB;MUKuOFkxPCEQvF2=MXPTRW5ITVJ?
RajiNYLydGoxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWXaZVBkUUN3ME2xNk43OTRizszNMXXTRW5ITVJ?
MDA-MB-415NFG4VmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWPxcoRyUUN3ME2xNk43PDR2IN88US=>M4TsfXNCVkeHUh?=
EFE-184MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYLJR|UxRTF{LkexNFYh|ryPNH7qNopUSU6JRWK=
BFTC-909MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVTyfI1EUUN3ME2xNk46OjR5IN88US=>NUC2O2J6W0GQR1XS
BHYMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmXXTWM2OD1zMz6zN|kh|ryPM1O3UHNCVkeHUh?=
YKG-1NET5Z3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYPFN4VXUUN3ME2xN{4{PzR7IN88US=>Mk\ZV2FPT0WU
EW-3M3vWNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2PmTGlEPTB;MUOuO|E3OyEQvF2=NEHQVIhUSU6JRWK=
HCC1143NHvYb5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHX1XYdKSzVyPUGzMlc1OzdizszNNWfrTHlmW0GQR1XS
REHNU[xSIh4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTF|Lki5PFIh|ryPM3fHcXNCVkeHUh?=
CESSMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoS0TWM2OD1zMz65OFg6KM7:TR?=MWTTRW5ITVJ?
EFM-19Ml:4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEOyNGhKSzVyPUG0MlEyOTJizszNNWjHcmNLW0GQR1XS
U031MmDsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml7STWM2OD1zND60NFg2KM7:TR?=NUDodIdlW0GQR1XS
ES1MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYPGTYVRUUN3ME2xOE41QDVzIN88US=>NHTFc4JUSU6JRWK=
HSC-3NHTPNGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWPJR|UxRTF2Lk[yNVUh|ryPMlzJV2FPT0WU
LOXIMVIMnHXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn[2TWM2OD1zND63NFY5KM7:TR?=NVLSS|FCW0GQR1XS
A388NVuz[4RuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWPJR|UxRTF2Lke1OVYh|ryPNYK5O2hrW0GQR1XS
KP-N-YSNXT5bYFST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWPzO|lmUUN3ME2xOE44PzNizszNM4LXR3NCVkeHUh?=
Capan-2MmPGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2[yeGlEPTB;MUSuO|g3KM7:TR?=MkjYV2FPT0WU
SKG-IIIaMnHmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFfIdXlKSzVyPUG0Mlg5PjJizszNMYXTRW5ITVJ?
HELNVviZXNoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV;zc2wyUUN3ME2xOE45QTl5IN88US=>MVfTRW5ITVJ?
BENM1;Qd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXzJR|UxRTF2Lkm3OlYh|ryPNHnq[WVUSU6JRWK=
MC116NEPLfJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH\WWWFKSzVyPUG1MlE2QTlizszNNU\6b|NKW0GQR1XS
IGROV-1MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlzHTWM2OD1zNT6yN|E4KM7:TR?=NWTieI9NW0GQR1XS
NCI-H1648NEG1bIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWHJR|UxRTF3LkWzNFUh|ryPNX\W[odXW0GQR1XS
ABC-1MnXaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmrtTWM2OD1zNT64NFM{KM7:TR?=M2Tq[nNCVkeHUh?=
EW-18NV;MPGJ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFPOOHRKSzVyPUG1Mlk6PzlizszNMULTRW5ITVJ?
BC-3NFjkVJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2WyW2lEPTB;MU[uNFU3OiEQvF2=MVLTRW5ITVJ?
NCI-H1437NICxPVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnHDTWM2OD1zNj6wOlY4KM7:TR?=NYPBN2FqW0GQR1XS
SCC-15NWOyRW9sT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3nHemlEPTB;MU[uNlgzPSEQvF2=NVfVVVVVW0GQR1XS
TTNWC4PHdkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGjhXZFKSzVyPUG2MlU5QDhizszNMonoV2FPT0WU
KINGS-1M1\neWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXjJR|UxRTF4LkiyO|Mh|ryPNGG3PW1USU6JRWK=
C32NUX5dVlTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFfwdHhKSzVyPUG2Mlk4OTdizszNMULTRW5ITVJ?
SBC-5MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlLITWM2OD1zNz6xOFc6KM7:TR?=MX\TRW5ITVJ?
NB1NWTCWIZ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIHMcGJKSzVyPUG3MlMyQDhizszNM4L4RnNCVkeHUh?=
EB-3NXW3O3czT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mlr0TWM2OD1zNz61O|Yh|ryPMU\TRW5ITVJ?
NCI-H748MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFy2bZhKSzVyPUG3MlcxOzVizszNM3W0cXNCVkeHUh?=
IST-SL1M37rNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGLmR4hKSzVyPUG3Mlc2OjZizszNNIjxUlNUSU6JRWK=
WM-115MlXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MknmTWM2OD1zNz64NFg2KM7:TR?=NIrEd4pUSU6JRWK=
NCI-H226NH;DZo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M37Z[mlEPTB;MUeuPVU1PiEQvF2=NEfXPGZUSU6JRWK=
CAL-33NYLhfXY1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWfoc4pIUUN3ME2xPE4zPzhzIN88US=>NW\6S|dUW0GQR1XS
SCC-4MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3O1SmlEPTB;MUiuN|IzQSEQvF2=MYjTRW5ITVJ?
RMG-IMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWjJR|UxRTF6Lk[5OFch|ryPMnTxV2FPT0WU
KOSC-2NYHkVGE2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXzJR|UxRTF6Lke3OFYh|ryPMlHCV2FPT0WU
A2058NGDWXm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWfJR|UxRTF6LkiyOVUh|ryPNVS4T|JXW0GQR1XS
HCC70M4PKVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYLJR|UxRTF7LkO4PVQh|ryPMmrRV2FPT0WU
C2BBe1MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3nIWmlEPTB;MUmuOFE1QCEQvF2=MVHTRW5ITVJ?
NCI-H650Mo\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFy3S3VKSzVyPUG5MlU5QTlizszNNV\LbmVzW0GQR1XS
CAL-72NXTk[VF7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXLJR|UxRTF7Lk[3N|ch|ryPMkPyV2FPT0WU
L-363M3TwR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmjhTWM2OD1{MD6wNlEzKM7:TR?=NVfrWHNzW0GQR1XS
SNU-423MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHuyTHdKSzVyPUKwMlExPDNizszNM3HOV3NCVkeHUh?=
PLC-PRF-5MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVTJR|UxRTJyLkO5NFYh|ryPNWLEWlVRW0GQR1XS
SW1463NX7wfIZ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1rsU2lEPTB;MkCuOFUzPSEQvF2=NHfhVHhUSU6JRWK=
769-PMmO5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{nodmlEPTB;MkCuOlc3QSEQvF2=MljPV2FPT0WU
DMS-79M{nHNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXu3XFdEUUN3ME2yNE45PDlizszNMVHTRW5ITVJ?
Saos-2NHHRTY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUDWbYFRUUN3ME2yNE46PTV4IN88US=>M3;FdXNCVkeHUh?=
CHP-126M1;ESmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIK4fJBKSzVyPUKxMlQ1PjJizszNMlHhV2FPT0WU
SW837M2rmV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NInWSphKSzVyPUKxMlQ6OzlizszNMYjTRW5ITVJ?
SHP-77NIjwPWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnzKTWM2OD1{MT62NVIzKM7:TR?=NHTsflZUSU6JRWK=
DBNE\qe41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEf2V|RKSzVyPUKxMlYyPDJizszNNUj2UGp1W0GQR1XS
ES5MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIrJNIVKSzVyPUKxMlY5PjRizszNNGHre2JUSU6JRWK=
COR-L23MkfWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnPDTWM2OD1{MT64NFUyKM7:TR?=M1zlNXNCVkeHUh?=
KU-19-19NEjjSnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWHJR|UxRTJzLki5PFIh|ryPMkDnV2FPT0WU
T84MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUHJR|UxRTJzLkm4NVkh|ryPMWnTRW5ITVJ?
NCI-H630MkDiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYHJR|UxRTJ{LkWzOlMh|ryPNFTadmFUSU6JRWK=
LU-165NWnTWJlQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIriWZlKSzVyPUKyMlU2PCEQvF2=NH;Hem5USU6JRWK=
COLO-792NXTKZ2JrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYLkUFNUUUN3ME2yNk44OTFzIN88US=>NHn1[|lUSU6JRWK=
CAL-62MorOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlWxTWM2OD1{Mj63OVE4KM7:TR?=NFHTRVJUSU6JRWK=
HCE-TMV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkjkTWM2OD1{Mj64OlA3KM7:TR?=M1fyW3NCVkeHUh?=
BB65-RCCNH20TnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX;JR|UxRTJ|LkCzOFQh|ryPMkLOV2FPT0WU
SiHaNUfCW|dsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4L0S2lEPTB;MkOuN|k3QCEQvF2=M17LVHNCVkeHUh?=
NCI-H2081NF;C[mpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3TGNGlEPTB;MkSuNFY1OSEQvF2=NG\XbWlUSU6JRWK=
U251MlW1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1fTO2lEPTB;MkSuNFY3QCEQvF2=MVvTRW5ITVJ?
LoVoMlPFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVfLTFVoUUN3ME2yOE46Ojh{IN88US=>M2riXnNCVkeHUh?=
GCIYNFnpT25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHfGcXNKSzVyPUK1MlI5PzdizszNNVXubIY4W0GQR1XS
NUGC-3NFvqXZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHPiboVKSzVyPUK1MlM{OTZizszNMk\pV2FPT0WU
LNCaP-Clone-FGCMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn7xTWM2OD1{NT6zOFk5KM7:TR?=M{HQZ3NCVkeHUh?=
PA-1NX7BXIZ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVjJR|UxRTJ3Lk[4N|Mh|ryPNGXVeZZUSU6JRWK=
OE33MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnvkTWM2OD1{NT62PFU{KM7:TR?=NYPwbY1MW0GQR1XS
HT-29MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlT4TWM2OD1{NT63PFc6KM7:TR?=MUHTRW5ITVJ?
RCM-1NXnBdGIyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUTJR|UxRTJ3Lkm2OVYh|ryPNEOyPVhUSU6JRWK=
NCI-H1522M{PyTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkDvTWM2OD1{NT65PVEyKM7:TR?=NFrWbWtUSU6JRWK=
LB373-MEL-DM1jFe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoTTTWM2OD1{Nj6xO|A5KM7:TR?=NUPY[mYzW0GQR1XS
NCI-H1436MlO4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHqwTlhKSzVyPUK2MlI4OzhizszNMUfTRW5ITVJ?
COLO-824NEjQO2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHPPVlhKSzVyPUK2MlQxODJizszNM1PjV3NCVkeHUh?=
CP50-MEL-BNF;i[JZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3zwWGlEPTB;Mk[uOVY4PSEQvF2=M1zZVHNCVkeHUh?=
EGI-1MlrYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlnZTWM2OD1{Nz6yOlk5KM7:TR?=NHG5NnNUSU6JRWK=
LAN-6MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFryWotKSzVyPUK3MlM2QThizszNM4fWfHNCVkeHUh?=
GAKM1XHfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnLtTWM2OD1{Nz60NlI2KM7:TR?=MmX1V2FPT0WU
MDA-MB-175-VIIMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mk[1TWM2OD1{Nz61NFU{KM7:TR?=NIjW[5hUSU6JRWK=
JVM-2Mo\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NInGepNKSzVyPUK3MlY3OjJizszNM17RVnNCVkeHUh?=
UACC-257MkjWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlTTTWM2OD1{Nz62PFc5KM7:TR?=M{\XbXNCVkeHUh?=
SW1783M3i4R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEf5O21KSzVyPUK3Mlc4QDNizszNNFfmeYlUSU6JRWK=
HT-3M2K0cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTJ6LkKxOlYh|ryPMnviV2FPT0WU
RLNWjBS2xYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYTJR|UxRTJ6LkW5NVEh|ryPNV:3SI51W0GQR1XS
TK10MlyyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGrzWGRKSzVyPUK4MlY2OzVizszNNHP0RphUSU6JRWK=
HT55NIHkOVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWPnTZNVUUN3ME2yPU4xPTZ3IN88US=>NUXvXlllW0GQR1XS
BT-20NVTQU5B3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk\aTWM2OD1{OT6wOVg3KM7:TR?=Mn35V2FPT0WU
TGBC24TKBNXTHW2ZKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4HEUWlEPTB;MkmuNVg{OSEQvF2=NXf0NnU1W0GQR1XS
HSC-2NFW5TotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYnWVmtUUUN3ME2yPU4{ODBzIN88US=>NV\oPIlyW0GQR1XS
COLO-205MnvjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWXJfmVQUUN3ME2yPU4{QTR2IN88US=>NIjoVmpUSU6JRWK=
GT3TKBNGfUSmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTJ7Lk[4O|ch|ryPM{\SVHNCVkeHUh?=
T47DNXzxPGlHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEnGS4dKSzVyPUK5Mlg2QDJizszNNWTQUlFPW0GQR1XS
OMC-1NXPa[YZqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NE\LPVJKSzVyPUOwMlE6OTlizszNNHXCSoRUSU6JRWK=
PFSK-1NWPsXo03T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4fYWmlEPTB;M{GuNlY2QSEQvF2=NUPURoZMW0GQR1XS
JEG-3NHjmc3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnjUTWM2OD1|MT6zOVYyKM7:TR?=NFP2cVlUSU6JRWK=
RDNGTyOlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVHJR|UxRTNzLkWxNVUh|ryPMknnV2FPT0WU
NCI-H64MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXzv[5RoUUN3ME2zNk41OTd7IN88US=>Mn7uV2FPT0WU
DMS-114NG\QZmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUf3W5ZvUUN3ME2zNk41OTh{IN88US=>M4e4[3NCVkeHUh?=
NCI-H661MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlzzTWM2OD1|Mj62OVAyKM7:TR?=M4n1S3NCVkeHUh?=
CAL-148M4\GZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2LzZWlEPTB;M{KuOlY3PSEQvF2=MlzQV2FPT0WU
HuP-T3NUKzNHRyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mon3TWM2OD1|Mj65N|M5KM7:TR?=M3TGZXNCVkeHUh?=
ES4MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH[2V|NKSzVyPUOzMlE4ODVizszNNV;ZNnQzW0GQR1XS
Ca9-22M{PBUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUfJR|UxRTN|LkS2NFEh|ryPNF7xdmpUSU6JRWK=
LP-1NFewfGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV;UeZN{UUN3ME2zOE4xQSEQvF2=M{[zNHNCVkeHUh?=
AU565NGnzeGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVLJS2N[UUN3ME2zOE42ODZ7IN88US=>MmDVV2FPT0WU
MDA-MB-453M2nt[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkfuTWM2OD1|NT6xOFI3KM7:TR?=NWDXRVF3W0GQR1XS
SNU-C1M1fST2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWHJR|UxRTN3LkG3NUDPxE1?NGXpPYpUSU6JRWK=
SW13MlzjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTN3LkSwO|Yh|ryPNGjjUZBUSU6JRWK=
NCI-H2122M2H4OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWey[W9qUUN3ME2zOU42PTl6IN88US=>NHnOSHVUSU6JRWK=
NCI-H1395NFO0Z3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUjJR|UxRTN3Lk[2PVEh|ryPM3PiV3NCVkeHUh?=
J-RT3-T3-5NHHlcZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{XpZmlEPTB;M{[uNFI6PCEQvF2=M4CzUnNCVkeHUh?=
COR-L279MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXXJR|UxRTN4LkG5PFEh|ryPMV;TRW5ITVJ?
ATN-1NHTnZ|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlTXTWM2OD1|Nj64OVE3KM7:TR?=NF3ieoFUSU6JRWK=
HCC2998NFyyfWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXTJR|UxRTN4Lki1O|Eh|ryPMVPTRW5ITVJ?
UM-UC-3NUjJZYxHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NI\nV4JKSzVyPUO2Mlg3PzVizszNNILEe2VUSU6JRWK=
DV-90MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTN4LkmwOlch|ryPMXHTRW5ITVJ?
ES8MkHSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEf1d4lKSzVyPUO2Mlk{OThizszNMVLTRW5ITVJ?
YAPCM2rmTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYWwXYpPUUN3ME2zOk46PjV2IN88US=>NUi4NmwyW0GQR1XS
HCC1599Mm[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkXnTWM2OD1|Nz6xOlE5KM7:TR?=MV;TRW5ITVJ?
UMC-11M3TwdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVXSSFBIUUN3ME2zO{4zPTB|IN88US=>NUHtNZhJW0GQR1XS
THP-1Mlr3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIf4dINKSzVyPUO3MlI5PjhizszNMmHBV2FPT0WU
OCUB-MMXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3;GWWlEPTB;M{euNlg6OSEQvF2=M2rqeHNCVkeHUh?=
NCI-H1693MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXHJR|UxRTN5LkOyN|Mh|ryPNYfCenR7W0GQR1XS
NCI-H345MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1;4OmlEPTB;M{euN|YzPCEQvF2=NX7EZmxpW0GQR1XS
COLO-800NWrweZd[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH73fG5KSzVyPUO3MlU3PyEQvF2=NEe1TmxUSU6JRWK=
COLO-320-HSRNHXUPW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoGyTWM2OD1|OD6zOFkzKM7:TR?=NIXEWXNUSU6JRWK=
NCI-H596NIXiWlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3XK[mlEPTB;M{iuOFQ5QSEQvF2=NWXjb|dbW0GQR1XS
NCI-H187MnzFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mo\jTWM2OD1|OD63N|Q1KM7:TR?=M2LKRnNCVkeHUh?=
ECC4M1PaW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2L2VmlEPTB;M{muNFgyPCEQvF2=MofvV2FPT0WU
KP-4NXPo[5UzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHfwPVJKSzVyPUO5MlEzOzVizszNMlGyV2FPT0WU
NCI-H2227MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NITCc5lKSzVyPUO5MlM6PDlizszNNIDCOWlUSU6JRWK=
22RV1M3zUdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlGyTWM2OD1|OT64N|k5KM7:TR?=MnzYV2FPT0WU
SASMXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV\lPG1EUUN3ME20NE4xQTZizszNNWr1XJNuW0GQR1XS
PANC-10-05NEWzNpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Moq2TWM2OD12MD6xPFI5KM7:TR?=NHv1dIxUSU6JRWK=
MDA-MB-468M1;PUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1LKb2lEPTB;NECuOVM1PiEQvF2=Mn;6V2FPT0WU
RPMI-7951NFXJTIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV7JR|UxRTRzLkKwO|Uh|ryPMYrTRW5ITVJ?
BB49-HNCNVvFfmNKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoXsTWM2OD12MT6yNVc6KM7:TR?=NH7pT5NUSU6JRWK=
23132-87NE[3dG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn7zTWM2OD12MT6yO|MzKM7:TR?=M2fKV3NCVkeHUh?=
HCC1569M{[w[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUnJR|UxRTRzLkK4PFUh|ryPMVHTRW5ITVJ?
CP66-MELMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2SwVWlEPTB;NEKuNVg5PiEQvF2=MoT2V2FPT0WU
K-562MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXXJR|UxRTR{LkK4OVQh|ryPM1;KTXNCVkeHUh?=
OCI-AML2M4DxUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2TkU2lEPTB;NEKuPFk4PCEQvF2=MkfWV2FPT0WU
SW756NIPSVHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MknjTWM2OD12Mz6wN|g5KM7:TR?=NI\SSHZUSU6JRWK=
M14NHTXZWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkXXTWM2OD12Mz6zNVg6KM7:TR?=NVr0XHA2W0GQR1XS
NCI-H1623M1zRZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV;JR|UxRTR|LkS2OEDPxE1?MVnTRW5ITVJ?
KNS-81-FDMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYnJR|UxRTR|Lke2NkDPxE1?MX\TRW5ITVJ?
TGBC1TKBMoHSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1flSGlEPTB;NEOuPVA6QSEQvF2=NW\mRnRXW0GQR1XS
RERF-LC-MSNV\DNXdPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIrZco9KSzVyPUSzMlkzQDFizszNM1Kxd3NCVkeHUh?=
PC-3MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXzzemoyUUN3ME20OE41OzR5IN88US=>NI\ybm5USU6JRWK=
HuP-T4MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoXKTWM2OD12ND60OFc1KM7:TR?=NYr6cHlIW0GQR1XS
NCI-H510ANXzh[|ZiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWrJR|UxRTR2LkewPEDPxE1?MVzTRW5ITVJ?
LB2518-MELM{fhbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NETLU3dKSzVyPUS0Mlc6OzdizszNNIHMdpRUSU6JRWK=
TE-5MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3fhTWlEPTB;NEWuPVU5OSEQvF2=NFzCWpJUSU6JRWK=
EW-24M{nQ[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRTR4LkG3NlMh|ryPM3PtT3NCVkeHUh?=
LB647-SCLCMVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXvJR|UxRTR4LkKxOVUh|ryPNFK4XmlUSU6JRWK=
NCI-H524NXjXWGVST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4rjWmlEPTB;NE[uO|E5PSEQvF2=NIfY[oFUSU6JRWK=
EW-11M1\LW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXSwUXNVUUN3ME20Ok46Ozd|IN88US=>NIK3OJNUSU6JRWK=
KALS-1M4\yN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYnJR|UxRTR5LkKwOlYh|ryPM3\T[HNCVkeHUh?=
BT-474MlPJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3PNV2lEPTB;NEeuOFIyPiEQvF2=M2\kRnNCVkeHUh?=
SK-N-ASMnu1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFLHeHdKSzVyPUS3Mlg5QCEQvF2=M{\X[3NCVkeHUh?=
HCC2157Mkm5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYnINVRyUUN3ME20PE4xPzZizszNNFHq[ldUSU6JRWK=
HCC1954M4jzc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVvJR|UxRTR6LkG3NFQh|ryPNGe0SHFUSU6JRWK=
FADUNYe0NoNqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV\JR|UxRTR6LkOwN|Eh|ryPNUPHT4FRW0GQR1XS
S-117MoTxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmW2TWM2OD12OD6zPFE2KM7:TR?=M1PJT3NCVkeHUh?=
LS-1034NGDqTmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnjETWM2OD12OD63NFY4KM7:TR?=NEHFO5lUSU6JRWK=
CAMA-1NEXOTIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1y0V2lEPTB;NEmuOVU1OyEQvF2=M2OzUHNCVkeHUh?=
LU-134-ANVfGW3lPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX3JR|UxRTR7LkiwPFUh|ryPNXnUc4xQW0GQR1XS
NCI-H1838M3e1XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF24SolKSzVyPUS5MlgxQDdizszNM1;j[XNCVkeHUh?=

... Click to View More Cell Line Experimental Data

In vivo In a mouse xenograft model of Ba/F3 cells expressing native Bcr-Abl, AP24534 (2.5 mg/kg and 5 mg/kg) prolongs mice median survival. In the xenograft model of Ba/F3 Bcr-AblT315I, AP24534 (10 mg/kg–50 mg/kg) significantly suppresses tumor growth. AP24534 (30 mg/kg) decreases the phosphorylated Bcr-Abl and phosphorylated CrkL levels in the tumors. [2]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

Peptide substrate phosphorylation assays with GST-Abl kinase domains The effect of AP24534 (0-320 nM) on GST-Abl kinase activity is assessed by using a synthetic peptide substrate (Abltide: EAIYAAPFAKKK). Assays are carried out at 30 °C for 15 min in 25 μL reaction mixture: 8 mM MOPS (pH 7), 0.2 mM EDTA, 50 μM Abltide, 30 mM MgCl2, 10 mM β-glycerol phosphate, 1 mM EGTA, 0.002% Brij-35, 0.4 mM DTT, 0.2 mg/mL BSA, 0.4 mM sodium orthovanadate, 10 nM WT or mutant GST-Abl kinase, and 100 µM ATP/γ-32[P]ATP (5000 cpm/pmol). Reactions are terminated by transferring a portion of the reaction mixture onto a p81 phosphocellulose filter and immersing in 0.75% phosphoric acid. Filters are washed 3 times in 0.75% phosphoric acid, rinsed in acetone, and air dried; phosphate incorporation is determined by scintillation counting. All results are corrected for background binding to the filters, as determined by omitting peptide substrate from the kinase reaction. Time course experiments to establish the linear range of enzymatic activity precedes kinase assays.

Cell Assay: [2]

Cell lines Ba/F3 cells expressing Bcr-Abl or a range of single mutations in the kinase domain of Bcr-Abl
Concentrations 0-625 nM
Incubation Time 72 hours
Method Ba/F3 cell lines are distributed in 96-well plates (4 × 103 cells/well) and incubated with AP24534 for 72 hours. Proliferation is measured using a methanethiosulfonate (MTS)-based viability assay (CellTiter96 Aqueous One Solution). All values are normalized to the control wells with no drug. IC50 values are reported as the mean of three independent experiments performed in quadruplicat

Animal Study: [1]

Animal Models Mouse xenograft models of Ba/F3 cells expressing Bcr-Abl or Bcr-AblT315I
Formulation Dissolved in 25 mM citrate buffer, pH 2.75
Dosages 2.5 mg/kg and 5 mg/kg for Ba/F3 Bcr-Abl; 2.5 mg/kg–50 mg/kg for Ba/F3 Bcr-AblT315I
Administration Oral gavage once daily

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] O'Hare T, et al. Cancer Cell, 2009, 16(5), 401-412.

[2] Huang WS, et al. J Med Chem, 2010, 53(12), 4701-4719.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT02829840 Not yet recruiting Leukemia|FLT3-Mutated Acute Myeloid Leukemia|FLT3-Mutated High-Risk Myelodysplastic Syndrome M.D. Anderson Cancer Center|Ariad Pharmaceuticals September 2016 Phase 1|Phase 2
NCT02776605 Not yet recruiting ALL PETHEMA Foundation June 2016 Phase 2
NCT01888562 Withdrawn Endometrial Neoplasms Washington University School of Medicine January 2016 --
NCT02627677 Recruiting Chronic Phase Chronic Myeloid Leukemia Ariad Pharmaceuticals December 2015 Phase 3
NCT02398825 Not yet recruiting Chronic Myeloid Leukemia|Chronic Phase|Adults Gruppo Italiano Malattie EMatologiche dellAdulto December 2015 Phase 2

view more

Chemical Information

Download Ponatinib (AP24534) SDF
Molecular Weight (MW) 532.56
Formula

C29H27F3N6O

CAS No. 943319-70-8
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 30 mg/mL (56.33 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 10 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 3-(2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide

Frequently Asked Questions

  • Question 1
    Is the pre-solubilized inhibitor suitable for in vivo whole animal studies? Whether the solvent contains any non-DMSO stabilizer?

    Answer: Our 10mM Ponatinib in DMSO solution is in pure DMSO and there is not other stabilizer added. You can use it for animal study. The vehicle we suggest for Ponatinib is: 30% PEG400/0.5% Tween80/5% Propylene glycol. It is a milky suspension used for oral gavage.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Bcr-Abl Products

  • PX-478 2HCl

    PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. Phase 1.

  • Defactinib (VS-6063, PF-04554878)

    Defactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.

  • SU6656

    SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.

  • Imatinib Mesylate (STI571)

    Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM in cell-free or cell-based assays, respectively.

  • Nilotinib (AMN-107)

    Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine myeloid progenitor cells.

    Features:A selective inhibitor of native and mutant Bcr-Abl.

  • Bafetinib (INNO-406)

    Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl/Lyn inhibitor with IC50 of 5.8 nM/19 nM in cell-free assays, does not inhibit the phosphorylation of the T315I mutant and is less potent to PDGFR and c-Kit. Phase 2.

    Features:Dual Bcr-Abl/Lyn inhibitor.

  • Degrasyn (WP1130)

    Degrasyn (WP1130) is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor and also suppresses Bcr/Abl, also a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT).

    Features:WP1130 has an advantage over imatinib mesylate in that its activity is not inhibited by a variety of Abl kinase mutations, including T315I.

  • DCC-2036 (Rebastinib)

    DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

    Features:A conformational control inhibitor of Abl1 and T315I Abl1.

  • GZD824 Dimesylate

    GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

  • GNF-2

    GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no activity to Flt3-ITD, Tel-PDGFR, TPR-MET and Tel-JAK1 transformed tumor cells.

Recently Viewed Items

Tags: buy Ponatinib (AP24534) | Ponatinib (AP24534) ic50 | Ponatinib (AP24534) price | Ponatinib (AP24534) cost | Ponatinib (AP24534) solubility dmso | Ponatinib (AP24534) purchase | Ponatinib (AP24534) manufacturer | Ponatinib (AP24534) research buy | Ponatinib (AP24534) order | Ponatinib (AP24534) mouse | Ponatinib (AP24534) chemical structure | Ponatinib (AP24534) mw | Ponatinib (AP24534) molecular weight | Ponatinib (AP24534) datasheet | Ponatinib (AP24534) supplier | Ponatinib (AP24534) in vitro | Ponatinib (AP24534) cell line | Ponatinib (AP24534) concentration | Ponatinib (AP24534) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us